772
Views
66
CrossRef citations to date
0
Altmetric
Review

The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 2921-2945 | Published online: 06 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinquan Yang, Peilong Liu, Yan Zhang, Jun Lu & Hongmou Zhao. (2023) Bioprinting-Enabled Biomaterials: A Cutting-Edge Strategy for Future Osteoarthritis Therapy. International Journal of Nanomedicine 18, pages 6213-6232.
Read now

Articles from other publishers (65)

Joan Calvet, María García-Manrique, Antoni Berenguer-Llergo, Cristóbal Orellana, Silvia Garcia Cirera, Maria Llop, Carlos Galisteo Lencastre, Marta Arévalo, Cristina Aymerich, Rafael Gómez, Néstor Albiñana Giménez & Jordi Gratacós. (2023) Metabolic and inflammatory profiles define phenotypes with clinical relevance in female knee osteoarthritis patients with joint effusion. Rheumatology 62:12, pages 3875-3885.
Crossref
Paweł Widera, Paco M.J. Welsing, Samuel O. Danso, Sjaak Peelen, Margreet Kloppenburg, Marieke Loef, Anne C. Marijnissen, Eefje M. van Helvoort, Francisco J. Blanco, Joana Magalhães, Francis Berenbaum, Ida K. Haugen, Anne-Christine Bay-Jensen, Ali Mobasheri, Christoph Ladel, John Loughlin, Floris P.J.G. Lafeber, Agnès Lalande, Jonathan Larkin, Harrie Weinans & Jaume Bacardit. (2023) Development and validation of a machine learning-supported strategy of patient selection for osteoarthritis clinical trials: the IMI-APPROACH study. Osteoarthritis and Cartilage Open 5:4, pages 100406.
Crossref
Gregor Bordon, Francis Berenbaum, Oliver Distler & Paola Luciani. (2023) Harnessing the multifunctionality of lipid-based drug delivery systems for the local treatment of osteoarthritis. Biomedicine & Pharmacotherapy 168, pages 115819.
Crossref
Ilja Boone, Margo Tuerlings, Rodrigo Coutinho de Almeida, Johannes Lehmann, Yolande Ramos, Rob Nelissen, Eline Slagboom, Peter de Keizer & Ingrid Meulenbelt. (2023) Identified senescence endotypes in aged cartilage are reflected in the blood metabolome. GeroScience.
Crossref
David J. Hunter, Jamie E. Collins, Leticia Deveza, Steven C. Hoffmann & Virginia B. Kraus. (2023) Biomarkers in osteoarthritis: current status and outlook — the FNIH Biomarkers Consortium PROGRESS OA study. Skeletal Radiology 52:11, pages 2323-2339.
Crossref
O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov & I. A. Bokova. (2023) Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology 16:3, pages 482-499.
Crossref
Win Min Oo, James Linklater, Kim L. Bennell, Shirley P. Yu, Vicky Duong & David J. Hunter. (2023) Inflammatory ultrasound features as prognostic factors of pain and functional outcomes following intra‐articular platelet‐rich plasma in knee osteoarthritis. International Journal of Rheumatic Diseases 26:8, pages 1540-1546.
Crossref
William J. Scheuing, Anthony M. Reginato, Mery Deeb & Sevtap Acer Kasman. (2023) The burden of osteoarthritis: Is it a rising problem?. Best Practice & Research Clinical Rheumatology, pages 101836.
Crossref
Kajetan Kiełbowski, Mariola Herian, Estera Bakinowska, Bolesław Banach, Tomasz Sroczyński & Andrzej Pawlik. (2023) The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis. International Journal of Molecular Sciences 24:14, pages 11655.
Crossref
Yulia S. Filatova & Mikhail V. Ilyin. (2023) The use of sodium hyaluronate to treat upper limb disease: A review. Terapevticheskii arkhiv 95:5, pages 438-443.
Crossref
James H. Chapman, Debolina Ghosh, Seyyedmorteza Attari, Chinedu C. Ude & Cato T. Laurencin. (2023) Animal Models of Osteoarthritis: Updated Models and Outcome Measures 2016–2023. Regenerative Engineering and Translational Medicine.
Crossref
Duygu Sarı Ak, Nazlı Helvacı, Ömer Alomari, Elif Bilge Yılmaz, Muhammed Munir Al-Jebaili & Alev Kural. (2023) The Role of DHEA, NGF, and ADAMTS5 Pathways in Osteoarthritis and Current Developments. Bagcilar Medical Bulletin 8:2, pages 113-126.
Crossref
Anais Defois, Nina Bon, Alexandre Charpentier, Melina Georget, Nicolas Gaigeard, Frederic Blanchard, Antoine Hamel, Denis Waast, Jean Armengaud, Ophelie Renoult, Claire Pecqueur, Yves Maugars, Marie-Astrid Boutet, Jerome Guicheux & Claire Vinatier. (2023) Osteoarthritic chondrocytes undergo a glycolysis-related metabolic switch upon exposure to IL-1b or TNF. Cell Communication and Signaling 21:1.
Crossref
Melissa A. Mercer, Jennifer L. Davis & Harold C. McKenzie. (2023) The Clinical Pharmacology and Therapeutic Evaluation of Non-Steroidal Anti-Inflammatory Drugs in Adult Horses. Animals 13:10, pages 1597.
Crossref
Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova & S. Z. Khakimova. (2023) New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council. Neurology, Neuropsychiatry, Psychosomatics 15:2, pages 134-146.
Crossref
Daniel Richard, Terence D. Capellini & Brian O. Diekman. (2023) Epigenetics as a mediator of genetic risk in osteoarthritis: role during development, homeostasis, aging, and disease progression. American Journal of Physiology-Cell Physiology 324:5, pages C1078-C1088.
Crossref
N. V. Chichasova & A. M. Lila. (2023) Glycosaminoglycan-peptide complex: data on the mechanism of action and efficacy in osteoarthritis. Meditsinskiy sovet = Medical Council:3, pages 127-135.
Crossref
Teresa Sadura-Sieklucka, Leszek Tomasz Czerwosz, Ewa Kądalska, Marcin Kożuchowski, Krystyna Księżopolska-Orłowska & Tomasz Targowski. (2023) Is Balance Training Using Biofeedback Effective in the Prophylaxis of Falls in Women over the Age of 65?. Brain Sciences 13:4, pages 629.
Crossref
Greg Gilles, Arjun Vohra, Dagoberto Robles, Mihra S. Taljanovic, Erin L. Ashbeck, Chelsea Caruso, Jeffrey Duryea, Edward J. Bedrick, Ali Guermazi & C. Kent Kwoh. (2023) Reliability and Validity of Single Axial Slice vs. Multiple Slice Quantitative Measurement of the Volume of Effusion-Synovitis on 3T Knee MRI in Knees with Osteoarthritis. Journal of Clinical Medicine 12:7, pages 2691.
Crossref
Nicholas A. HouseholderAkshay RaghuramKofi AgyareSkyler ThipaphayMimi Zumwalt. (2023) A Review of Recent Innovations in Cartilage Regeneration Strategies for the Treatment of Primary Osteoarthritis of the Knee: Intra-articular Injections. Orthopaedic Journal of Sports Medicine 11:4, pages 232596712311559.
Crossref
Jianjing Lin, Shicheng Jia, Weifei Zhang, Mengyuan Nian, Peng Liu, Li Yang, Jianwei Zuo, Wei Li, Hui Zeng & Xintao Zhang. (2023) Recent Advances in Small Molecule Inhibitors for the Treatment of Osteoarthritis. Journal of Clinical Medicine 12:5, pages 1986.
Crossref
C.B. Little. (2023) Cholesterol, systemic inflammation, interleukin-1β, and osteoarthritis risk — aligning animal models with specific patient endotypes provides novel insights. Osteoarthritis and Cartilage 31:3, pages 298-299.
Crossref
Rafael Heiss, Jean-Denis Laredo, Wolfgang Wirth, Mylène P. Jansen, Anne C.A. Marijnissen, Floris Lafeber, Agnes Lalande, Harrie H. Weinans, Francisco J. Blanco, Francis Berenbaum, Margreet Kloppenburg, Ida K. Haugen, Klaus Engelke & Frank W. Roemer. (2023) Quantitative CT of the knee in the IMI-APPROACH osteoarthritis cohort: Association of bone mineral density with radiographic disease severity, meniscal coverage and meniscal extrusion. Bone 168, pages 116673.
Crossref
Roland Takács, Szilárd Póliska, Tamás Juhász, Krisztina B. Barna & Csaba Matta. (2023) Isolation of High‐Quality Total RNA from Small Animal Articular Cartilage for Next‐Generation Sequencing. Current Protocols 3:3.
Crossref
Mylène P. Jansen, Frank W. Roemer, Anne Karien C. A. Marijnissen, Margreet Kloppenburg, Francisco J. Blanco, Ida K. Haugen, Francis Berenbaum, Floris P. J. G. Lafeber, Paco M. J. Welsing, Simon C. Mastbergen & Wolfgang Wirth. (2023) Exploring the differences between radiographic joint space width and MRI cartilage thickness changes using data from the IMI-APPROACH cohort. Skeletal Radiology.
Crossref
Sebastian Staebler, Adrian Lichtblau, Slavyana Gurbiel, Thomas Schubert, Alexander Riechers, Ulrike Rottensteiner-Brandl & Anja Bosserhoff. (2023) MIA/CD-RAP Regulates MMP13 and Is a Potential New Disease-Modifying Target for Osteoarthritis Therapy. Cells 12:2, pages 229.
Crossref
Sevdalina Nikolova Lambova. (2023) Knee Osteoarthritis—How Close Are We to Disease-Modifying Treatment: Emphasis on Metabolic Type Knee Osteoarthritis. Life 13:1, pages 140.
Crossref
守建 朱. (2023) The Relationship between the Infrapatellar Fat Pad and Knee Osteoarthritis. Advances in Clinical Medicine 13:10, pages 15465-15469.
Crossref
Shengfa Li, Peihua Cao, Tianyu Chen & Changhai Ding. (2023) Latest insights in disease-modifying osteoarthritis drugs development. Therapeutic Advances in Musculoskeletal Disease 15, pages 1759720X2311698.
Crossref
Sara Tenti, Olivier Bruyère, Sara Cheleschi, Jean-Yves Reginster, Nicola Veronese & Antonella Fioravanti. (2023) An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis. Therapeutic Advances in Musculoskeletal Disease 15, pages 1759720X2311586.
Crossref
Nicole Schäfer & Susanne Grässel. (2022) Targeted therapy for osteoarthritis: progress and pitfalls. Nature Medicine 28:12, pages 2473-2475.
Crossref
Yuwen Wang, Ling Liu, Zhicheng Le & Andy Tay. (2022) Analysis of Nanomedicine Efficacy for Osteoarthritis. Advanced NanoBiomed Research 2:12, pages 2200085.
Crossref
Jaqueline Lourdes Rios, Dora Sapède, Farida Djouad, Anna E. Rapp, Annemarie Lang, Jonathan Larkin, Christoph Ladel & Ali Mobasheri. (2022) Animal Models of Osteoarthritis Part 1–Preclinical Small Animal Models: Challenges and Opportunities for Drug Development. Current Protocols 2:11.
Crossref
Carmen Velasco-Salgado, Gloria María Pontes-Quero, Luis García-Fernández, María Rosa Aguilar, Kyra de Wit, Blanca Vázquez-Lasa, Luis Rojo & Cristina Abradelo. (2022) The Role of Polymeric Biomaterials in the Treatment of Articular Osteoarthritis. Pharmaceutics 14:8, pages 1644.
Crossref
Jomarien García-Couce, Timo Schomann, Chih Kit Chung, Ivo Que, Carla Jorquera-Cordero, Gastón Fuentes, Amisel Almirall, Alan Chan & Luis J. Cruz. (2022) Thermosensitive Injectable Hydrogels for Intra-Articular Delivery of Etanercept for the Treatment of Osteoarthritis. Gels 8:8, pages 488.
Crossref
Silvia Ravalli, Federico Roggio, Benedetta Magrì, Giovanni Lauretta, Giuseppe Broggi, Rosario Caltabiano, Giada Maria Vecchio, Gaetano Magro, Carla Loreto, Alessandro Castorina & Giuseppe Musumeci. (2022) Immunohistochemical evaluation of autotaxin and lubricin in mild osteoarthritic rat model performing moderate physical activity. Acta Histochemica 124:6, pages 151936.
Crossref
Shenglei Yang, Mingli Sun & Xinan Zhang. (2022) Protective Effect of Resveratrol on Knee Osteoarthritis and its Molecular Mechanisms: A Recent Review in Preclinical and Clinical Trials. Frontiers in Pharmacology 13.
Crossref
Evelyn P. Murphy & Daniel Crean. (2022) NR4A1-3 nuclear receptor activity and immune cell dysregulation in rheumatic diseases. Frontiers in Medicine 9.
Crossref
Peng Zhao, Dong Liu, Chunying Song, Di Li, Xinzhu Zhang, Ivana Horecny, Fengqi Zhang, Yuna Yan, Linghang Zhuang, Jing Li, Suxing Liu, Yuchang Mao, Jun Feng, Jian Liu & Weikang Tao. (2022) Discovery of Isoindoline Amide Derivatives as Potent and Orally Bioavailable ADAMTS-4/5 Inhibitors for the Treatment of Osteoarthritis. ACS Pharmacology & Translational Science 5:7, pages 458-467.
Crossref
Rebecca Mae Black, Lisa L. Flaman, Karin Lindblom, Susan Chubinskaya, Alan J. Grodzinsky & Patrik Önnerfjord. (2022) Tissue catabolism and donor-specific dexamethasone response in a human osteochondral model of post-traumatic osteoarthritis. Arthritis Research & Therapy 24:1.
Crossref
Vicente Sifre, Carme Soler, Sergi Segarra, José Ignacio Redondo, Luis Doménech, Amadeo Ten-Esteve, Laura Vilalta, Luis Pardo-Marín & Claudio Iván Serra. (2022) Improved Joint Health Following Oral Administration of Glycosaminoglycans with Native Type II Collagen in a Rabbit Model of Osteoarthritis. Animals 12:11, pages 1401.
Crossref
Winni Gao, Hamza Hasan, Devon E. Anderson & Whasil Lee. (2022) The Role of Mechanically-Activated Ion Channels Piezo1, Piezo2, and TRPV4 in Chondrocyte Mechanotransduction and Mechano-Therapeutics for Osteoarthritis. Frontiers in Cell and Developmental Biology 10.
Crossref
Federico Angelini, Paweł Widera, Ali Mobasheri, Joseph Blair, André Struglics, Melanie Uebelhoer, Yves Henrotin, Anne CA Marijnissen, Margreet Kloppenburg, Francisco J Blanco, Ida K Haugen, Francis Berenbaum, Christoph Ladel, Jonathan Larkin, Anne C Bay-Jensen & Jaume Bacardit. (2022) Osteoarthritis endotype discovery via clustering of biochemical marker data. Annals of the Rheumatic Diseases 81:5, pages 666-675.
Crossref
Siam-Yee Lee, Pooi-Fong Wong, Juliana Jamal & Margaret M. Roebuck. (2022) Naturally-derived endoplasmic reticulum stress inhibitors for osteoarthritis?. European Journal of Pharmacology 922, pages 174903.
Crossref
Tonia L. Vincent, Tamara Alliston, Mohit Kapoor, Richard F. Loeser, Linda Troeberg & Christopher B. Little. (2022) Osteoarthritis Pathophysiology. Clinics in Geriatric Medicine 38:2, pages 193-219.
Crossref
Win Min Oo. (2022) Prospects of Disease-Modifying Osteoarthritis Drugs. Clinics in Geriatric Medicine 38:2, pages 397-432.
Crossref
Yuji Kohno, Mitsuru Mizuno, Kentaro Endo, Nobutake Ozeki, Hisako Katano, Mikio Matsumoto, Haruka Kaneko, Yuji Takazawa, Hideyuki Koga & Ichiro Sekiya. (2022) Yields of mesenchymal stromal cells from synovial fluid reflect those from synovium in patients with rheumatoid arthritis. Tissue and Cell 75, pages 101727.
Crossref
Paula Carpintero-Fernández, Marta Varela-EirínAlejandro García-YusteIñaki López-DíazJosé Ramón CaeiroMaría D. Mayán. (2022) Osteoarthritis: Mechanistic Insights, Senescence, and Novel Therapeutic Opportunities. Bioelectricity 4:1, pages 39-47.
Crossref
John Loughlin. (2022) Translating osteoarthritis genetics research: challenging times ahead. Trends in Molecular Medicine 28:3, pages 176-182.
Crossref
D.A. Young, M.J. Barter & J. Soul. (2022) Osteoarthritis year in review: genetics, genomics, epigenetics. Osteoarthritis and Cartilage 30:2, pages 216-225.
Crossref
A. Latourte & P. Richette. (2022) Inhibition of ADAMTS-5: the right target for osteoarthritis?. Osteoarthritis and Cartilage 30:2, pages 175-177.
Crossref
Alicja Nowaczyk, Dawid Szwedowski, Ignacio Dallo & Jacek Nowaczyk. (2022) Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment. International Journal of Molecular Sciences 23:3, pages 1566.
Crossref
C. Meurot, C. Martin, L. Sudre, J. Breton, C. Bougault, R. Rattenbach, K. Bismuth, C. Jacques & F. Berenbaum. (2022) Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis. Scientific Reports 12:1.
Crossref
Josef Jampilek, Jan Hosek & Pavel Bobal. (2022) Investigation of the Effect of Selected Piperazine-2,5-Diones on Cartilage-Related Cells. Investigation of the Effect of Selected Piperazine-2,5-Diones on Cartilage-Related Cells.
玉龙 朱. (2022) The Role of Infrapatellar Fat Pad in Knee Osteoarthritis. Advances in Clinical Medicine 12:06, pages 5160-5165.
Crossref
Win Min Oo & David J. Hunter. (2022) Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210902.
Crossref
Heungdeok Kim, Jinwon Seo, Yunsin Lee, Kiwon Park, Thomas A. Perry, Nigel K. Arden, Ali Mobasheri & Heonsik Choi. (2022) The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities. Therapeutic Advances in Musculoskeletal Disease 14, pages 1759720X2210859.
Crossref
Kaihu Li, Penghui Zhang, Yong Zhu, Mauro Alini, Sibylle Grad & Zhen Li. (2021) Establishment of an Ex Vivo Inflammatory Osteoarthritis Model With Human Osteochondral Explants. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Yifeng Cao, Yifeng Ma, Yi Tao, Weifeng Lin & Ping Wang. (2021) Intra-Articular Drug Delivery for Osteoarthritis Treatment. Pharmaceutics 13:12, pages 2166.
Crossref
Hélène Kaplon, Yufei Luo, Frédéric De Ceuninck, Agnès Lalande, Sophie Courtade-Gaiani, Laurence Laigle & Philippe Moingeon. (2021) Applications of transcriptomics in support of drug development for osteoarthritis. Osteoarthritis and Cartilage Open 3:4, pages 100221.
Crossref
Yumei Cao, Su'an Tang & Changhai Ding. (2021) Inflammatory phenotype of osteoarthritis and its potential therapies. Rheumatology & Autoimmunity 1:2, pages 92-100.
Crossref
Josef Jampilek & Daniela Placha. (2021) Advances in Use of Nanomaterials for Musculoskeletal Regeneration. Pharmaceutics 13:12, pages 1994.
Crossref
Win Min Oo & David J Hunter. (2021) Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review. BioDrugs 35:6, pages 611-641.
Crossref
Candice Bohaud, Rafael Contreras-Lopez, Jholy De La Cruz, Claudia Terraza-Aguirre, Mingxing Wei, Farida Djouad & Christian Jorgensen. (2021) Pro-regenerative Dialogue Between Macrophages and Mesenchymal Stem/Stromal Cells in Osteoarthritis. Frontiers in Cell and Developmental Biology 9.
Crossref
Martin Philipp Dieterle, Ayman Husari, Bernd Rolauffs, Thorsten Steinberg & Pascal Tomakidi. (2021) Integrins, cadherins and channels in cartilage mechanotransduction: perspectives for future regeneration strategies. Expert Reviews in Molecular Medicine 23.
Crossref